10.1 C
London
Sunday, December 10, 2023

Emerging Growth Conference 66 January 10 & 11 - Register now

ASX Commentary

Discussion about stocks trading on the Australian Stock Exchange ASX from professionals in the Australian stock and investing profession

Rat’s Rant – The Russian Bomb Edition

What's Hot - TSC, FFR, CCA, DEV, CAV, RIM, MYQ, 88E, BNL & 3DA What's Not - NEA & BRNWhat's Doing - Thanks to the reader...

Rat’s Rant – The Oprah Winfrey Edition

What's Hot - LRS, DTZ, BRN, OAU, BGT, CDP, CZR, CRL & VUL What's Not - SBR & MGTWhat's Doing - CBF To subscribe to this...

Rat’s Rant – The George Bush Terror Edition

Rat's Rant - The George Bush Terror Edition

Rat’s Rant – The Weekend Probe Edition

What's Hot - TKM, ARO, OAR, BOA, ADD, CLQ, NVA, MGR & DCL What's Not - GSW & ED1 What's Doing - LBY (Laybuy Group - new BNPL float listing Monday RMB - Rat's Multi Builder (It's long like my sentiment at the moment)

Rat’s Rant – The Black Friday Edition

What's Hot - LIN, ASN, ADN, BAR, GAS, ICU, PM1, TSO, VTI, DAV, CHN, TNY & GGGWhat's Not - My FingersWhat's Doing - Hump...

AdAlta (ASX: 1AD) IMPORTANT PHASE I EXTENSION CLINICAL STUDY OF AD-214 APPROVED

29 June 2023 ASX Announcement IMPORTANT PHASE I EXTENSION CLINICAL STUDY OF AD-214 APPROVED Key highlights: Human Research Ethics Committee (HREC) has approved Phase I extension...

Rat’s Rant – The Nintendo Edition

Rat's Rant - The Nintendo Edition

AD-214 RETURNS TO CLINICAL STUDIES

Key points: First dosing of AD-214 achieved in Phase I extension study On track to obtain interim results in 2023, full results in...

Rat’s Rant – The German Late Night Blitz Edition

Rat's Rant - The German Late Night Blitz Edition What's Hot - GLA, AOA, SBR, WCG, FFR, LBY, MGT, RSH, DRE, OAR, BNL & OLL What's Not - PXS & HMX What's Doing - The Great Unwashed Protesters Closet to the Pin - Leader board update and zero commentary

Rat’s Rant – The Golden Girls Edition

Rat's Rant - The Golden Girls Edition

Latest News